5-HT3 receptors.
D000818:Animals; D001007:Anxiety / Q000188:drug therapy / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002032:Bulimia / Q000188:drug therapy / Q000503:physiopathology; D003001:Cloning, Molecular; D006801:Humans; D015640:Ion Channel Gating / Q000502:physiology; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D044406:Receptors, Serotonin, 5-HT3 / Q000145:classification / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy* / Q000503:physiopathology; D012702:Serotonin Antagonists / Q000494:pharmacology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D015398:Signal Transduction; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000503:physiopathology
D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists